A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties

DC Litzinger, CM Ransone, LD Ralph… - Journal of …, 1995 - Elsevier
The chelating agent diethylenetriaminepentaacetic acid (DTPA) has been conjugated site-
specifically to the N-terminus of recombinant human interleukin-2 (rhIL-2) by reaction with …

[引用][C] Synthetic immunomodulating agents

VS Georgiev - Medicinal Research Reviews, 1990 - Wiley Online Library
Recent advances in our understanding of the complex and multifaceted relationships and
interactions between different components of the immune system have enhanced our …

Control of Inflammation Using Drug Delivery Strategies in in vitro Models

PR Wardwell - 2015 - search.proquest.com
Regulation of inflammation is a crucial component of the immune system in response to
injury and infection. In otherwise healthy individuals, an initial acute inflammatory response …

Injectable butyrate-prodrug micelles induce long-acting immune modulation and suppress autoimmune arthritis in mice

S Cao, E Budina, R Wang, M Sabados, A Solanki… - bioRxiv, 2023 - biorxiv.org
Dysbiosis is linked to autoimmune diseases such as rheumatoid arthritis (RA), where
microbial metabolites, such as short chain fatty acids (SCFAs), mediate the so-called gut …

Attenuation of GVHD in a SCID-Hu mouse model following therapy with a rationally designed immunomodulatory peptide.

JS Sandhu, S Iyer, J Woo, R Buelow - Transplantation, 1999 - journals.lww.com
Recently, we reported on the rational design of novel immunomodulatory peptides.
Administration of these peptides into mice and rats resulted in the upregulation of …

Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells

VR Cicinnati, J Hou, M Lindemann, PA Horn… - …, 2009 - journals.lww.com
Background. Mycophenolic acid (MPA) is the pharmacologically active compound of the
immunosuppressive drug mycophenolate mofetil. Dendritic cells (DC) are the key to …

Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases

MK Skytthe, JH Graversen, SK Moestrup - International journal of …, 2020 - mdpi.com
The macrophage is a key cell in the pro-and anti-inflammatory response including that of the
inflammatory microenvironment of malignant tumors. Much current drug development in …

Preclinical evidence for the glucocorticoid-sparing potential of a dual toll-like receptor 7/8 inhibitor in autoimmune diseases

A Deshmukh, A Pereira, N Geraci, E Tzvetkov… - … of Pharmacology and …, 2024 - ASPET
Toll-like receptor 7 (TLR7) and TLR8 are single-stranded RNA-sensing endosomal pattern
recognition receptors that evolved to defend against viral infections. However, aberrant …

MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists

A Bagchi, EA Herrup, HS Warren, J Trigilio… - The Journal of …, 2007 - journals.aai.org
TLRs sense components of microorganisms and are critical host mediators of inflammation
during infection. Different TLR agonists can profoundly alter inflammatory effects of one …

[图书][B] Neutrophils in the spotlight: In dendritic cell-driven adaptive immunity

FMJ Hafkamp - 2023 - dare.uva.nl
The daily challenge of dodging pathogenic infections is carried out by the two arms of our
immune system: the innate and the adaptive immune system. Innate immune cells, like …